European Archives - Page 1101 of 1195 - European Medical Journal

EMJ

Should Type 2 Diabetes Management Be More of a Priority in Post-Acute Coronary Syndrome Patients? Opening Remarks

Prof Ele Ferrannini of the University of Pisa School of Medicine, Pisa, Italy, welcomes congress delegates to a Takeda-sponsored symposium held at the…

EMJ

Frost & Sullivan Award to Ebit (Esaote Group) for Suitestensa Technically Advanced Cardiovascular Information System Integration Platform – CVIS PACS

Genoa, 18 November 2015 – Frost & Sullivan, a global organization collaborating with international companies to leverage innovation and…

EMJ

SCHILLER Enables the Export of ECG Raw Data: Resting ECGs, Exercise ECGs and Resting Rhythms

SCHILLER’s declared goal is to make therapy-relevant data accessible in digital form throughout the hospital. Thanks to the latest development, we have…

Biologic Therapies: Clinical Practice in a Changing Environment

Biological therapies have been in use for treating psoriasis for a decade now, and they have greatly improved disease outcomes and quality of life…

The Skin Microbiome in Patients with Acne Vulgaris

Changes in the composition of cutaneous microbial communities have been linked to several chronic inflammatory skin diseases, including acne.

A Rejuvenation Therapy of Medical Needling and 3D-Matrixlift® is Safe and Improves the Elasticity of the Skin

The use of platelet-rich plasma and growth factors is emerging as an anti-ageing regimen for the skin.

Acne and Systemic Diseases

Acne is a very common, multifactorial, complex, and chronic disease of the pilosebaceous unit that affects approximately 85% of adolescent patients and…

Pyoderma Gangrenosum: A Mini-Review

Pyoderma gangrenosum (PG) is a rare, chronic neutrophilic dermatosis of unknown aetiology that usually presents with necrotising ulcers, although…

Quality of Life Evaluation in Psoriasis Patients Starting a Biological Treatment: The Importance of a More Comprehensive Assessment of Disease Burden

Psoriasis is a chronic condition that has a significant negative impact on a patient’s quality of life (QoL).

Staphylococcus Aureus and Atopic Dermatitis: Which Came First, the Chicken or the Egg?

Atopic dermatitis (AD) is a highly pruritic, chronic inflammatory skin disease that affects up to 25% of children and 10% of adults.